Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Alexander

Showing results (851-860 of 1,212) with videos related to

Pageof 122
Sort By:
Journal of the American College of Cardiology|February 4, 2022
Antithrombotic Therapy in Patients With Atrial Fibrillation After Acute Coronary Syndromes or Percutaneous InterventionRalf E Harskamp, Alexander C Fanaroff, Renato D Lopes, et al.
Circulation|October 9, 2014
Growth differentiation factor 15, a marker of oxidative stress and inflammation, for risk assessment in patients with atrial fibrillation: insights from the Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation (ARISTOTLE) trialLars Wallentin, Ziad Hijazi, Ulrika Andersson, et al.
Journal of Surgical Oncology|June 15, 2019
Targeted muscle reinnervation in oncologic amputees: Early experience of a novel institutional protocolJohn H Alexander, Sumanas W Jordan, Julie M West, et al.
Current Problems in Diagnostic Radiology|June 22, 2002
Dual-energy digital subtraction chest radiography: technical considerationsGary J Whitman, Loren T Niklason, Meenakshi Pandit, et al.
Open Heart|November 30, 2018
Obesity paradox on outcome in atrial fibrillation maintained even considering the prognostic influence of biomarkers: insights from the ARISTOTLE trialRoopinder K Sandhu, Justin A Ezekowitz, Ziad Hijazi, et al.
Journal of the American Heart Association|September 1, 2020
Association of Different Estimates of Renal Function With Cardiovascular Mortality and Bleeding in Atrial FibrillationZiad Hijazi, Christopher B Granger, Stefan H Hohnloser, et al.
Journal of Pain Research|November 16, 2017
The prevalence of probable neuropathic pain in the US: results from a multimodal general-population health surveyMarco D DiBonaventura, Alesia Sadosky, Kristen Concialdi, et al.
American Heart Journal|September 29, 2014
Clinical outcomes of hybrid coronary revascularization versus coronary artery bypass surgery in patients with diabetes mellitusRalf E Harskamp, Patrick F Walker, John H Alexander, et al.
American Heart Journal|September 29, 2009
Predictors of 30-day mortality in patients with refractory cardiogenic shock following acute myocardial infarction despite a patent infarct arteryJason N Katz, Amanda L Stebbins, John H Alexander, et al.
Journal of Thrombosis and Thrombolysis|June 5, 2013
Warfarin use and long-term outcomes in patients with acute myocardial infarction and atrial fibrillationJames A Nelson, John P Vavalle, Christopher H May, et al.
Pageof 122

Showing results (851-860 of 1,212) with videos related to

Sort By:
Pageof 122
Journal of the American College of Cardiology|February 4, 2022
Antithrombotic Therapy in Patients With Atrial Fibrillation After Acute Coronary Syndromes or Percutaneous InterventionRalf E Harskamp, Alexander C Fanaroff, Renato D Lopes, et al.
Circulation|October 9, 2014
Growth differentiation factor 15, a marker of oxidative stress and inflammation, for risk assessment in patients with atrial fibrillation: insights from the Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation (ARISTOTLE) trialLars Wallentin, Ziad Hijazi, Ulrika Andersson, et al.
Journal of Surgical Oncology|June 15, 2019
Targeted muscle reinnervation in oncologic amputees: Early experience of a novel institutional protocolJohn H Alexander, Sumanas W Jordan, Julie M West, et al.
Current Problems in Diagnostic Radiology|June 22, 2002
Dual-energy digital subtraction chest radiography: technical considerationsGary J Whitman, Loren T Niklason, Meenakshi Pandit, et al.
Open Heart|November 30, 2018
Obesity paradox on outcome in atrial fibrillation maintained even considering the prognostic influence of biomarkers: insights from the ARISTOTLE trialRoopinder K Sandhu, Justin A Ezekowitz, Ziad Hijazi, et al.
Journal of the American Heart Association|September 1, 2020
Association of Different Estimates of Renal Function With Cardiovascular Mortality and Bleeding in Atrial FibrillationZiad Hijazi, Christopher B Granger, Stefan H Hohnloser, et al.
Journal of Pain Research|November 16, 2017
The prevalence of probable neuropathic pain in the US: results from a multimodal general-population health surveyMarco D DiBonaventura, Alesia Sadosky, Kristen Concialdi, et al.
American Heart Journal|September 29, 2014
Clinical outcomes of hybrid coronary revascularization versus coronary artery bypass surgery in patients with diabetes mellitusRalf E Harskamp, Patrick F Walker, John H Alexander, et al.
American Heart Journal|September 29, 2009
Predictors of 30-day mortality in patients with refractory cardiogenic shock following acute myocardial infarction despite a patent infarct arteryJason N Katz, Amanda L Stebbins, John H Alexander, et al.
Journal of Thrombosis and Thrombolysis|June 5, 2013
Warfarin use and long-term outcomes in patients with acute myocardial infarction and atrial fibrillationJames A Nelson, John P Vavalle, Christopher H May, et al.
Pageof 122